Samuraciclib (ICEC0942) hydrochloride
Samuraciclib (ICEC0942) hydrochloride is a new, orally bioavailable CDK7 inhibitor with an IC50 of 40nM. The IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher. ICEC0942 (CT7001) promotes cell cycle arrest and apoptosis.
Trivial name | CT7001 hydrochloride |
Catalog Number | S8722 |
Molecular Formula | C22H31ClN6O |
CAS# | 1805789-54-1 |
Inchi | InChI=1S/C22H30N6O.ClH/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29;/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27);1H/t17-,19+;/m1./s1 |
Inchi Key | YMNPLAHCOLEZJE-ZFNKBKEPSA-N |
SMILES | CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NCC4CCNCC4O.Cl |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/icec0942-hydrochloride.html |
Additional Information | https://file.selleck.cn/downloads/struct/icec0942-chemical-structure-s8722.gif |